Cerebrospinal fluid CXCL10 is associated with the presence of low-level CSF HIV during suppressive antiretroviral therapy
(Journal of Neuroimmunology 2021, 353:577493) Cerebrospinal fluid CXCL10 is associated with the presence of low-level CSF HIV during suppressive antiretroviral therapy.
Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study
(JAIDS 2021, 87(5):1196-1204) Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study
Increasing the performance of a fully automated quantitative assay for the detection of circulating HBV pregenomic RNA
(presented at 2021 HEP DART in Los Cabos, Mexico) Summary: A presentation of the increased analytical performance of a fully automated assay for the detection and quantitation of hepatitis B pregenomic RNA in CHB patients.
(presented at 2019 CVS in Savannah, GA) Summary: A presentation of the analytical performance of a new assay for the detection and quantitation of hepatitis B pregenomic RNA in CHB patients.
Prevelence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy
(The Journal of Infectious Diseases 2017, 215:105-13) Summary: bioMONTR Labs’ proprietary HIV-1 SuperLow Assay was utilized to measure HIV-1 RNA levels in CSF and plasma from adults taking suppressive ART to assess if the association between HIV-1 RNA discordance and HAND may reflect compartmentalization.
(Presented at 2017 CVS in Savannah, GA) Summary: A presentation of the validation for using the eMAG with bioMONTR Labs’ HIV-1 SuperLow assay, a RESEARCH USE ONLY for detection of single copy HIV-1 RNA.
Full Automation and Flexibility for Extraction of Free Circulating Nucleic Acids: Proof of Concept for eMAG™
(Presented at 2017 CVS in Savannah, GA) Summary: This study evaluated the use of eMAG for fully automated extraction of free circulating nucleic acids.
(Hum Virol Retrovirol 2015, 2(7); 00071) Summary: The study evaluated workflow organization and automation improvements to the ViroSeq HIV-1 Genotyping System through the use of semi-automated extraction platforms, automated amplicon quantification, and high-throughput sequencing platforms.
(Presented at 2015 AMP in Austin, TX) Summary: This study evaluated the functionality and performance of a novel prototype plasma separation card that collects capillary blood, separates cellular components by gravity and stores plasma at ambient temperature pending analysis.
Presented at 2015 ASN in San Diego, CA) Summary: This study described the detection of CXCL9/MIG and CXCL-10/IP-10 in urine spectrophotometrically, in combination with a novel collection device ViveST, eliminating the need for cold chain storage.